Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
10 Julho 2023 - 5:30PM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader
in life science research and clinical diagnostic products, will
report its financial results for the second quarter of 2023 on
Thursday, August 3, 2023, following the close of the market.
Management will discuss these results in a conference call
scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
To participate, call 888-259-6580 within the U.S., access code:
94809387. From outside the U.S., participants can join the call via
the Audience Entry URL, access code: 94809387.
A live webcast of the conference call will also be available in
the "Investor Relations" section of the company’s website under
"Events & Presentations" at investors.bio-rad.com. A replay of
the webcast will be available for up to a year.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a leader in
developing, manufacturing, and marketing a broad range of products
for the life science research and clinical diagnostics markets.
Based in Hercules, California, Bio-Rad operates a global network of
research, development, manufacturing, and sales operations with
over 8,300 employees and $2.8 billion in revenues in 2022. Our
customers include universities, research institutions, hospitals,
food safety and environmental quality laboratories, and
biopharmaceutical companies. Together, we develop innovative,
high-quality products that advance science and save lives. To learn
more, visit bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230710399913/en/
Investor Contact: Edward Chung, Investor Relations
510-741-6104 ir@bio-rad.com
Media Contact: Anna Gralinska, Corporate Communications
510-741-6643 pr@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Bio Rad Laboratories (NYSE:BIO)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024